Back HIV/AIDS HIV/AIDS Topics HIV Treatment

San Francisco Reports Progress in "Getting to Zero" HIV Prevention and Treatment Effort

San Francisco made good progress in HIV prevention and treatment during 2015, and its successes have brought the city national and worldwide attention. But more work is needed to "get to zero," especially reaching groups currently underserved by current efforts. "Like Silicon Valley in the tech world, San Francisco is where innovation happens in the HIV world," Diane Havlir, chief of the HIV/AIDS division at San Francisco General Hospital, said at a December 1 forum commemorating World AIDS Day.alt

Read more:

Not Enough Is Being Done to Provide Universal Access to HIV Treatment, Advocates Say

An international coalition of AIDS treatment advocates, clinical providers, and people living with HIV has released an analysis showing than fewer than 1 in 10 people with HIV live in countries that provide antiretroviral therapy (ART) for all regardless of CD4 count, contrary to international treatment guidelines. The activists urged more funding to make global recommendations for universal treatment a reality.

alt

Read more:

UNAIDS and WHO Highlight Fast-Track Efforts to Expand HIV Prevention and Treatment

In advance of World AIDS Day, UNAIDS and the World Health Organization (WHO) released new reports describing successful local efforts to reduce new HIV infections and get more people living with HIV on effective treatment. The global World AIDS Day theme for 2015 is the Fast-Track to ending the AIDS epidemic by 2030 as part of the United Nations Sustainable Development Goals.With progress to date exceeding expectations, world leaders are now calling for accelerated efforts to achieve more ambitious goals.

alt

Read more:

WHO Issues Recommendations on Linkage to Care, Retention to Help Bring HIV Treatment to All

The World Health Organization (WHO) has issued new recommendations on how to organize services in order to promote linkage to care and retention in care as part of its new guidelines recommending antiretroviral treatment for all adults and adolescents diagnosed with HIV.

alt

Read more:

Genvoya Pill with Tenofovir Alafenamide Added to Recommended HIV Regimens

The Department of Health and Human (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents has added the recently approved Genvoya single-tablet regimen containing elvitegravir and the new tenofovir alafenamide to its list of recommended regimens for initial HIV treatment.

alt

Read more:

December 1 Is World AIDS Day

Tuesday, December 1, is World AIDS Day, an opportunity both to remember the millions of people worldwide who have been lost to the epidemic, and to address remaining gaps in HIV prevention, care, and treatment. The U.S. World AIDS Day theme, "The Time to Act is Now," and the global theme of getting on the Fast-Track to end the AIDS epidemic both underscore how the remarkable progress to date has spurred efforts to achieve more ambitious goals.

alt

Read more:

EACS 2015: Dual Therapy with Protease Inhibitors and Lamivudine Suppresses HIV

Dual antiretroviral regimens consisting of only a boosted HIV protease inhibitor (lopinavir/ritonavir or atazanavir) and a single inexpensive and well-tolerated NRTI may be enough to achieve and maintain HIV suppression in a most patients starting antiretroviral therapy (ART) for the first time or switching from a standard triple regimen, according to a pair of studies presented at the EACS 15th European AIDS Conference last month in Barcelona.

alt

Read more: